Annual CFO
-$17.69 M
+$8.08 M+31.36%
December 31, 2023
Summary
- As of February 7, 2025, EVAX annual cash flow from operations is -$17.69 million, with the most recent change of +$8.08 million (+31.36%) on December 31, 2023.
- During the last 3 years, EVAX annual CFO has fallen by -$5.25 million (-42.23%).
- EVAX annual CFO is now -788.55% below its all-time high of -$1.99 million, reached on December 31, 2018.
Performance
EVAX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
N/A
September 1, 2024
Summary
- EVAX quarterly cash flow from operations is not available.
Performance
EVAX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
N/A
September 1, 2024
Summary
- EVAX TTM cash flow from operations is not available.
Performance
EVAX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
EVAX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.4% | - | - |
| 3 y3 years | -42.2% | - | - |
| 5 y5 years | -788.5% | - | - |
EVAX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.4% | ||||
| 5 y | 5-year | -152.0% | +31.4% | ||||
| alltime | all time | -788.5% | +31.4% |
Evaxion Biotech A/S Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$17.69 M(-31.4%) | - | - |
| Dec 2022 | -$25.77 M(+17.5%) | - | - |
| Jun 2022 | - | -$5.19 M(-36.6%) | -$23.79 M(-8.8%) |
| Mar 2022 | - | -$8.19 M(+98.9%) | -$26.08 M(+18.9%) |
| Dec 2021 | -$21.93 M | -$4.12 M(-34.6%) | -$21.93 M(-1.4%) |
| Sep 2021 | - | -$6.29 M(-15.9%) | -$22.24 M(+18.9%) |
| Jun 2021 | - | -$7.49 M(+85.6%) | -$18.71 M(+38.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$4.04 M(-8.7%) | -$13.52 M(+8.7%) |
| Dec 2020 | -$12.44 M(+77.2%) | -$4.42 M(+59.9%) | -$12.44 M(+55.1%) |
| Sep 2020 | - | -$2.77 M(+20.1%) | -$8.02 M(+52.6%) |
| Jun 2020 | - | -$2.30 M(-21.9%) | -$5.25 M(+78.1%) |
| Mar 2020 | - | -$2.95 M | -$2.95 M |
| Dec 2019 | -$7.02 M(+252.5%) | - | - |
| Dec 2018 | -$1.99 M | - | - |
FAQ
- What is Evaxion Biotech A/S annual cash flow from operations?
- What is the all time high annual CFO for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S annual CFO year-on-year change?
- What is the all time high quarterly CFO for Evaxion Biotech A/S?
- What is the all time high TTM CFO for Evaxion Biotech A/S?
What is Evaxion Biotech A/S annual cash flow from operations?
The current annual CFO of EVAX is -$17.69 M
What is the all time high annual CFO for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high annual cash flow from operations is -$1.99 M
What is Evaxion Biotech A/S annual CFO year-on-year change?
Over the past year, EVAX annual cash flow from operations has changed by +$8.08 M (+31.36%)
What is the all time high quarterly CFO for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high quarterly cash flow from operations is -$2.30 M
What is the all time high TTM CFO for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high TTM cash flow from operations is -$2.95 M